COVAXIN(BBV152)
BBIL-BBV152/154-2021
Phase 2 mab completed
Quick answer
COVAXIN(BBV152) for Corona Virus Infection is a Phase 2 program (mab) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biotech Pharmaceutical Co.,
- Indication
- Corona Virus Infection
- Phase
- Phase 2
- Modality
- mab
- Status
- completed